RxDoctor Payments Data

Houston Hodges, MD

Family Medicine · St Petersburg, FLNPI 1508489204

Payments from drug & device makers

$2,887in general payments, 2019–2025

Across 116 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$636
  • AbbVie$492
  • Amgen$243
  • Novo Nordisk$220
  • Exact Sciences$186
  • Lilly USA, LLC$178
  • plus $932 from 11 others

What the payments were for

  • Food & beverage$2,887100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,887 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$26,176
Medicare patients
69
Services billed
340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$25,808
JardianceEmpagliflozin12$15,845
OzempicSemaglutide12$13,753
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,727
Rosuvastatin Calcium42$1,044
Atorvastatin Calcium72$604
Albuterol Sulfate HfaAlbuterol Sulfate26$555
Pravastatin Sodium20$437
Bupropion XlBupropion Hcl13$329
Levothyroxine Sodium37$324
Lisinopril53$289
Amlodipine Besylate34$288
Omeprazole15$270
Tamsulosin Hcl26$249
Pantoprazole Sodium19$220

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$113$25,80826 claims
Boehringer IngelheimJardiance$87$15,84512 claims
Novo NordiskOzempic$220$13,75312 claims
AstraZenecaBreztri Aerosphere$636$7,72712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →